Maipl Therapeutics, Inc.

Hot off the presses today, here's the White House executive order outlining actions to advance women's health. This is the year we accelerate women's health funding, with leading partners in the government, industry and academia. Here we go! #3not30 Carolyn M. Mazure Morag Grassie Lucy Perez Carolee Lee Alice Zheng Christina Jenkins, MD Liz Powell Jamie White Sanskriti Thakur Sasha Kelemen Johanna (Rodriguez) Grossman, PhD Frederique Welgryn Trine Bartholdy Celine Gounder, MD, ScM, FIDSA Rachele Berria, MD PhD Cindy Hoots (she, her) Patricia Bradley Michal Tsur Anna Mason Sabrina Johnson Janine Austin Clayton Daan Besamusca Jesse Argon Kimi Iguchi Chris Benecchi Elia Stupka Paolo Di Giorgio Tanja Dowe Women's Health Access Matters SteelSky Ventures Avestria Ventures Elana Berkowitz Jessica Karr Mira Kaufman Sarah Wu Daisy Wolf Gaurica Chacko Elizabeth Garner

A Nature Medicine article from Nature Portfolio features encouraging developments for #endometriosis research, citing the JAX/UConn Health partnership as one of the driving forces for #womenshealth: #endometriosisawarenessmonth 🎗️

Insufficient funding for endometriosis research persists as a pressing issue Last night, FEMaLe project was aired on TV 2 Danmark (Go' Aften Live). I highlighted how the funding allocated to understand, diagnose, treat, and raise awareness about #endometriosis doesn't match its prevalence and impact in the European Union: We need more Action Plans for Endometriosis in Europe. 🔍 The Funding Gap Despite the significant burden endometriosis places on individuals and society, research funding remains disproportionately low. This has a direct impact on diagnosis, treatment options, and the overall quality of life for those affected. 🌐 Global Impact Endometriosis knows no borders. It affects people worldwide, and the lack of funding exacerbates disparities in healthcare access and outcomes. It's time for a united effort to address this issue on a global scale. 💡 Why Funding Matters a. Research Breakthroughs: Adequate funding fuels research, leading to breakthroughs in understanding the causes and developing more effective treatments. b. Early Detection: Increased funding can contribute to the development of better diagnostic tools, enabling early detection and intervention. c. Patient Support: Funding is crucial for support programs, educational initiatives, and community outreach, ensuring that those affected receive the care and understanding they deserve. 🤝 Call to Action Let's come together to advocate for increased funding for endometriosis. Whether you're a healthcare professional, researcher, patient, or ally, your voice matters. Share this post, engage in conversations, and support organizations working tirelessly to make a difference. 🌺 Spread the Word The more we talk about endometriosis and its funding challenges, the closer we get to a future where those affected can live without the burden of pain and uncertainty. Tag organizations, share your experiences, and let's make sure endometriosis gets the attention and funding it deserves. Together, we can make a difference! Feel free to customise this post based on your personal experiences or additional information you'd like to include. #female #letsmakelifebetter #1in10  #fempowerment #findingendometriosis #femtech #endometriosisawareness #womenshealth Lone Hummelshoj Dorte Rytter Mette Nyegaard Krina Zondervan Attila Bokor Camilla Fabricius Nilufer Rahmioglu Dmitrijs Bļizņuks Sebastiaan Meijer Jayanth Raghothama Veronique Bouchet Steve Gardner Nemanja Todić Adrienn Salamon Health - Aarhus University SURGAR Nicolas Bourdel Francesco Mureddu Association EndoFrance Endometriosis UK Endometriosis Australia Endometriose Stichting Endometriose Faellesskabet European Endometriosis League Endométriose Belgique World Health Organization Pernille Weiss Central Denmark EU Office (CDEU) BioInnovation Institute Medicon Valley Alliance Hugo Vankelecom Bharati Shivalkar https://lnkd.in/dVNAZrvF

Elevate your understanding of women's health with our expert lineup at the Women's Health Symposium! From impressive insights into cardiac well-being, advancements in cancer care, to revolutionary therapies for heart failure – our keynote speakers are set to unveil the future of #womenhealth. Join us for a symphony of knowledge and innovation. 🔸Dr. Indu Poornima, MD - Professor of Medicine at Drexel University, specializing in #cardiac care and women's heart health. 🔸Dr. Kirk Peterson, MD - Professor of Medicine Emeritus at UCSD, with over 50 years of expertise in cardiology. 🔸Dr. Bhawanjit Brar, Ph.D. - CEO and Founder of Jaan Biotherapeutics LLC Biotherapeutics, dedicated to developing therapeutic solutions for heart failure. 🔸Dr. Leticia Varella, MD - Professor of #Medicine Emeritus at Dana Faber Cancer Institute, a clinical expert in breast cancer care and research. 🔸Dr. Catharine Marshall, MD - OB-GYN at Scripps La Jolla Hospitals, bringing over 20 years of experience in women's health. 🔸Dr. Beth J Hoffman, Ph.D. - Founder and CEO at Origami Therapeutics, Inc., with 25+ years of expertise in CNS #drugdiscovery. 🔸Dr. Andreas G. Bader, Ph.D. - Chief Scientific Officer at Triumvira Immunologics, Inc., specializing in drug development and cellular therapies. Don't miss this opportunity to gain insights from leaders shaping the future of women's health. 📆 Wednesday, January 31th ⏲ 9am to 7pm 🏢 10918 Technology Pl #SanDiego, CA Save the date and register now to be part of the conversation that shapes the path to well-being! https://lnkd.in/dt4DUUd7 Set up a display, showcasing your product or service at our Women's Health Symposium by joining The Startup Market! https://lnkd.in/dSPMxYi9

It is with delight and excitement to announce Yoshiyuki Fukase, Vice President of Medicinal Chemistry and CMC, staring in January 2024. Yoshi brought nearly 20 years of experience from Ferring, Takeda, and the MSKCC/Rockefeller Univ./Weill Cornell Tri-Institutional Therapeutics Discovery Institute. He has made breakthrough discoveries and delivered multiple clinical compounds as leader of projects across multiple organizations. Yoshi is an author or inventor of over 40 publications and patents. Welcome to Maipl Therapeutics!

Insights on how prostaglandin F2α initiates labor, by transforming the myometrium from a myofibroblast to smooth muscle, pro-labour like state. #maipltx celebrates this important scientific discovery through a collaboration between former #ferring colleagues and the Andrew Blanks lab!